MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30.

Income Overview

Net Income
-$16,370K
EPS
-$0.36
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Collaboration revenue
0 0 --
Research and development
11,634 13,143 13,120 12,528
General and administrative
4,092 4,399 4,871 4,596
Total operating expenses
15,726 17,542 17,991 17,124
Operating loss
-15,726 -17,542 -17,991 -17,124
Interest income
697 850 997 1,598
Interest expense
1,341 1,301 1,263 1,244
Loss on extinguishment of debt
0 0 --
Other income, net
0 11 168 97
Total other (expense) income
-644 -440 -98 451
Net loss
-16,370 -17,982 -18,089 -16,673
Net loss per common share, basic (in usd per share)
-0.36 -0.4 -0.4 -0.38
Net loss per common share, diluted (in usd per share)
-0.36 -0.4 -0.4 -0.38
Weighted-average common shares outstanding, basic (in shares)
45,804,042 44,981,746 44,827,159 43,704,836
Weighted-average common shares outstanding, diluted (in shares)
45,804,042 44,981,746 44,827,159 43,704,836
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$16,370K Total other (expense)income-$644K Operating loss-$15,726K Interest income$697K Interest expense$1,341K Total operatingexpenses$15,726K General andadministrative$4,092K Research and development$11,634K

Werewolf Therapeutics, Inc. (HOWL)

Werewolf Therapeutics, Inc. (HOWL)